GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Biotech Acquisition Co (NAS:BIOT) » Definitions » 5-Year Yield-on-Cost %

Biotech Acquisition Co (Biotech Acquisition Co) 5-Year Yield-on-Cost % : 0.00 (As of May. 23, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Biotech Acquisition Co 5-Year Yield-on-Cost %?

Biotech Acquisition Co's yield on cost for the quarter that ended in Sep. 2022 was 0.00.


The historical rank and industry rank for Biotech Acquisition Co's 5-Year Yield-on-Cost % or its related term are showing as below:



BIOT's 5-Year Yield-on-Cost % is not ranked *
in the Diversified Financial Services industry.
Industry Median: 3.745
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Biotech Acquisition Co's 5-Year Yield-on-Cost %

For the Shell Companies subindustry, Biotech Acquisition Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotech Acquisition Co's 5-Year Yield-on-Cost % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Biotech Acquisition Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Biotech Acquisition Co's 5-Year Yield-on-Cost % falls into.



Biotech Acquisition Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Biotech Acquisition Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Biotech Acquisition Co  (NAS:BIOT) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Biotech Acquisition Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Biotech Acquisition Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotech Acquisition Co (Biotech Acquisition Co) Business Description

Traded in Other Exchanges
N/A
Address
545 West 25th Street, 20th Floor, New York, NY, USA, 10001
Website
Biotech Acquisition Co is a blank check company.
Executives
Albert F Hummel director, officer: Chief Investment Officer PO BOX 3407, RANCHO SANTA FE CA 92067
Biotech Sponsor Llc 10 percent owner 545 W. 25TH ST., 20TH FLOOR, NEW YORK NY 10001
Bruno Montanari director 545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001
Ivan Jarry officer: Chief Operating Officer 545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001
Paul Bernard director 545 WEST 25TH STREET 20TH FL, NEW YORK NY 10001
Aaron Kim director 545 WEST 25TH STREET 20TH FL, NEW YORK NY 10001
Michael Schleifer director, 10 percent owner, officer: Chief Executive Officer 545 WEST 25TH STREET 20TH FLOOR, NEW YORK NY 10001
Thomas Fratacci officer: CFO & Treasurer 545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001

Biotech Acquisition Co (Biotech Acquisition Co) Headlines

From GuruFocus